Overview
My research focuses on genetic predictors of progression in non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma (HCC). I have investigated predictors of clinical progression in non-alcoholic fatty liver disease using the Duke NAFLD clinical database and biorepository. I find the genetic and modifiable risk factors for liver disease fascinating, particularly because of the potential for clinical intervention before cirrhosis or HCC are established.
Current Appointments & Affiliations
Assistant Professor of Medicine
·
2024 - Present
Medicine, Gastroenterology,
Medicine
Recent Publications
Predictors of Respiratory Failure Development in a Multicenter Cohort of Inpatients With Cirrhosis.
Journal Article Am J Gastroenterol · April 1, 2024 INTRODUCTION: Hospitalized patients with cirrhosis can develop respiratory failure (RF), which is associated with a poor prognosis, but predisposing factors are unclear. METHODS: We prospectively enrolled a multicenter North American cirrhosis inpatient co ... Full text Link to item CiteRacial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease
Journal Article Metabolism and Target Organ Damage · January 1, 2024 Metabolic dysfunction-associated steatotic liver disease (MASLD) has an increasing prevalence, morbidity, and mortality both within the United States and globally. Here, we review newer evidence demonstrating racial and ethnic disparities that exist in the ... Full text CiteFatty Liver Disease: Enter the Metabolic Era.
Journal Article Curr HIV/AIDS Rep · December 2023 PURPOSE OF REVIEW: The goal of this review is to summarize the recent literature linking HIV to metabolic dysfunction-associated steatotic liver disease (MASLD). This is a pressing issue due to the scale of the MASLD epidemic and the urgent need for preven ... Full text Link to item CiteRecent Grants
Genomic Imprinting in the Development of NAFLD
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2028Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis
ResearchCo Investigator · Awarded by University of Texas - Southwestern · 2023 - 2027The Southeastern Liver Health Cohort Study
ResearchCo Investigator · Awarded by North Carolina State University · 2023 - 2027View All Grants
Education, Training & Certifications
Harvard Medical School ·
2014
M.D.